Rhode Island Connecticut New Jersey Delaware Maryland Virginia Pennsylvania New York Maine Vermont New Hampshire Massachusetts Washington, DC Arizona Texas New Mexico Utah Idaho Montana Wyoming Colorado North Dakota South Dakota Nebraska Kansas Oklahoma Louisiana Arkansas Missouri Iowa Minnesota Mississippi Florida Wisconsin Illinois Tennessee Alabama Georgia South Carolina North Carolina Kentucky Michigan Indiana Ohio West Virginia Nevada California Washington Hawaii Alaska Oregon

Shifting Diagnostic Paradigms for Improved Treatment and Surveillance of Fetal Alcohol Spectrum Disorder in DSM-V

October 19, 2012  |     |     |   0 Comment
When:
November 14, 2012 @ 6:00 PM – 11:00 PM
Where:
Suburban Hospital,
8600 Old Georgetown Rd
Bethesda,MD 20814
USA
Cost:
Free to CAPSGW members in good standing. Guests and Non-Members: Members are encouraged to bring guests. The fee for guests and non-members is $25 per person.
Contact:
Diane Berman301-299-1393E-mail

This presentation will include a clinically relevant historical and epidemiological overview of Fetal Alcohol Spectrum Disorder and plans for inclusion of prenatal alcohol exposure in DSM-V as an etiology of childhood mental disorders.
As the quintessential neurodevelopmental teratogen, a patient’s history of in utero alcohol exposure has a number of clinical implications for psychiatrists. Alcohol-related neurodevelopmental disorder is a brain-based condition with co-morbid medical issues that impact treatment decisions, confound psychopharmacologic management, and necessitate a multidisciplinary team approach. A neurodevelopmental paradigm to formulation, diagnosis, treatment planning, and long term management can prevent unnecessary morbidity, improve prognosis, and prevent recidivist juvenile behaviors. Relevant case studies will augment the discussion.
This presentation is appropriate for clinicians and professionals working with children of adoption, families affected by alcohol abuse, and those serving high risk populations. As the most prevalent and preventable cause of learning disabilities, cognitive impairment, and executive functioning issues, this topic is particularly relevant to clinicians working with children and adolescents who may have inadvertently been exposed to moderate to heavy social drinking.
Learning Objectives:
(1)
Discuss the historical shifts in nomenclature from dysmorphic Fetal Alcohol Syndrome to non-dysmorphic Alcohol-related Neurodevelopmental Disorder.
(2)
Explain population-based differences in prenatal exposure rates (US and international).
(3)
Highlight the neurodevelopmental sequellae associated with prenatal alcohol exposure.
(4)
Review common medical co-morbidities in FASD that may be contraindications to medications.
(5)
Outline a neurodevelopmental formulation and treatment model for long term clinical management.

Please RSVP by Wednesday, November 7. If you make a reservation and cannot attend, you must cancel no later than noon on Friday, November 9 to avoid a cancellation charge of $25.